MiMedx Group, Inc. announced it will release its operating and financial results for the third quarter ending September 30, 2026, after market close on October 28, 2026. The company's senior management will hold a webcast and conference call at 4:30 p.m. Eastern Time the same day to discuss the results. Investors can access the call via phone or webcast, with a replay available for 30 days on MiMedx's website. This update is important for stakeholders tracking the company's performance in wound care and healthcare product innovation.
MiMedx Group's upcoming Q3 2026 results call is noted here with Pluang's health sector data for context. Among 150 health-sector US stocks on Pluang as of Oct 15, 2026 03:02 WIB, 90 advanced and 60 declined. Halozyme Therapeutics rose 6.60% to USD 116.86 with a strong 71% buy order activity and a very short typical hold time of 1 day, contrasting with Heron Therapeutics and Hims and Hers Health, which fell 6.89% and 6.70% to USD 0.36 and USD 27.72 respectively, with lower buy interest and longer hold times.
Stephany Insurance LLC, a fourth-generation independent agency in Wexford, PA, is highlighted in a new 2026 guide for helping small businesses in Pittsburgh's North Hills identify and close insurance coverage gaps caused by rising premiums. The guide...
The Knowles-Rowland House, a $13.96 million redevelopment project by Bread of Life Inc., has opened in Midtown Houston, providing 31 permanent supportive housing units for individuals exiting chronic homelessness. The building, formerly a fire-damage...
ATLAS SP Partners, majority owned by Apollo funds, announced the pricing of $750 million senior notes due 2032 with a fixed 6.25% interest rate until November 2031, then switching to a floating rate based on SOFR plus a spread. The notes, issued by A...
Bending Spoons led market gainers with a 41.2% rise after Berkshire Hathaway increased its stake to 4% by investing an additional $330 million. Antelope Enterprise gained 36.4%, and NEXGEL rose 32.1% following a reverse stock split. Liquidia advanced...
The Law Offices of Frank R. Cruz is investigating Alignment Healthcare following a whistleblower lawsuit claiming the company misclassified $8-10 million in expenses to inflate its adjusted EBITDA and stock price. This alleged accounting manipulation...
